Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Pfizer
You must be logged in to create a new article
All Articles
Marina Siqueira
Jul 9, 2024
•
Featured
Patent Litigation
ANDA Litigation
Mixed Verdict in Pfizer v. Moderna COVID-19 Vaccine Patent Dispute
On July 2nd, the High Court in London ruled in favor of Moderna, determining that Pfizer infringed one of Moderna's... Read More
Mikele Bicolli
Aug 28, 2022
•
Patent Litigation
Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for... Read More
Mikele Bicolli
Aug 27, 2022
•
Patent Litigation
Pfizer and BioNTech Sued Again Over Covid Vaccine Technology, This Time by Moderna
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More
Elisabeth Manville
Jan 27, 2012
The FDA approves new Pfizer drug to treat kidney cancer
Pfizer announced that the U.S. Food and Drug Administration has approved their kidney cancer drug INLYTA (axinib). The treatment will... Read More
Alejandro Freixes
Oct 26, 2011
World Intellectual Property Organization holds an innovation consortium
  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and... Read More
Alejandro Freixes
Oct 24, 2011
Studies show no extra risk with Pfizer smoking drug
  (Reuters) - Smokers who take Pfizer's pill Chantix to help them quit do not have a higher risk of... Read More